CA2308639A1 - Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor - Google Patents
Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor Download PDFInfo
- Publication number
- CA2308639A1 CA2308639A1 CA002308639A CA2308639A CA2308639A1 CA 2308639 A1 CA2308639 A1 CA 2308639A1 CA 002308639 A CA002308639 A CA 002308639A CA 2308639 A CA2308639 A CA 2308639A CA 2308639 A1 CA2308639 A1 CA 2308639A1
- Authority
- CA
- Canada
- Prior art keywords
- benzenesulfonamide
- pyrazol
- trifluoromethyl
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6388997P | 1997-10-31 | 1997-10-31 | |
| US60/063,889 | 1997-10-31 | ||
| PCT/US1998/022246 WO1999022720A2 (en) | 1997-10-31 | 1998-10-27 | Selective cyclooxygenase-2 inhibitors against premature labor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2308639A1 true CA2308639A1 (en) | 1999-05-14 |
Family
ID=22052179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002308639A Abandoned CA2308639A1 (en) | 1997-10-31 | 1998-10-27 | Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
Country Status (9)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1353664A2 (en) * | 2000-06-08 | 2003-10-22 | The Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
| PL1534305T3 (pl) | 2003-05-07 | 2007-03-30 | Osteologix As | Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994026731A1 (en) * | 1993-05-13 | 1994-11-24 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| EP0889724A1 (en) * | 1996-02-27 | 1999-01-13 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
| US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
-
1998
- 1998-10-27 BR BR9813164-8A patent/BR9813164A/pt not_active Application Discontinuation
- 1998-10-27 WO PCT/US1998/022246 patent/WO1999022720A2/en active IP Right Grant
- 1998-10-27 CA CA002308639A patent/CA2308639A1/en not_active Abandoned
- 1998-10-27 JP JP2000518654A patent/JP2001521889A/ja not_active Withdrawn
- 1998-10-27 AU AU11926/99A patent/AU758566B2/en not_active Ceased
- 1998-10-27 EP EP98955026A patent/EP1027048A2/en not_active Ceased
- 1998-10-29 ZA ZA9809876A patent/ZA989876B/xx unknown
- 1998-10-30 AR ARP980105483A patent/AR014000A1/es not_active Application Discontinuation
- 1998-10-30 TW TW087118094A patent/TW577739B/zh not_active IP Right Cessation
- 1998-10-30 TW TW092134686A patent/TW200404535A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001521889A (ja) | 2001-11-13 |
| AU1192699A (en) | 1999-05-24 |
| AR014000A1 (es) | 2001-01-31 |
| EP1027048A2 (en) | 2000-08-16 |
| TW200404535A (en) | 2004-04-01 |
| TW577739B (en) | 2004-03-01 |
| WO1999022720A2 (en) | 1999-05-14 |
| BR9813164A (pt) | 2000-08-22 |
| AU758566B2 (en) | 2003-03-27 |
| WO1999022720A3 (en) | 1999-08-26 |
| ZA989876B (en) | 1999-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6342510B1 (en) | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist | |
| US5990148A (en) | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | |
| EP0880362B1 (en) | Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist | |
| US6136839A (en) | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | |
| EP0888127B1 (en) | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors | |
| AU745797B2 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders | |
| US6407140B1 (en) | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | |
| US20020035156A1 (en) | Combination therapy in the prevention of cardiovascular disorders | |
| US20070072861A1 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders | |
| AU758566B2 (en) | Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor | |
| EP1400242A1 (en) | Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20080618 |